Using fractional exhaled nitric oxide (FeNO) to diagnose steroid‐responsive disease and guide asthma management in routine care

Price, David; Ryan, Dermot; Burden, Annie; von Ziegenweidt, Julie; Gould, Shuna; Freeman, Daryl; Gruffydd‐Jones, Kevin; Copland, Anne; Godley, Clifford; Chisholm, Alison; Thomas, Mike

doi:10.1186/2045-7022-3-37

Public

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid‐responsive disease and guide asthma management in routine care

Published in Clinical and Translational Allergy • Jan 1, 2013

Authors:

David Price

Dermot Ryan

Annie Burden

Abstract

BACKGROUND: Fractional exhaled nitric oxide (FeNO) is a surrogate marker of eosinophilic airway inflammation and good predictor of corticosteroid response. AIM: To evaluate how FeNO is being used to guide primary care asthma management in the United Kingdom (UK) with a view to devising practical alg...

Subject

Exhaled nitric oxide

Medicine

Asthma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!